Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6D74

Direct Activation of the Executioner Domain of MLKL by a Select Repertoire of Inositol Phosphates

Summary for 6D74
Entry DOI10.2210/pdb6d74/pdb
NMR InformationBMRB: 30458
DescriptorMixed lineage kinase domain-like protein (1 entity in total)
Functional Keywordsmembrane, lipid binding protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight18318.13
Authors
Royappa, G.C.,McNamara, D.E.,Moldoveanu, T. (deposition date: 2018-04-24, release date: 2019-05-15, Last modification date: 2024-05-15)
Primary citationMcNamara, D.E.,Dovey, C.M.,Hale, A.T.,Quarato, G.,Grace, C.R.,Guibao, C.D.,Diep, J.,Nourse, A.,Cai, C.R.,Wu, H.,Kalathur, R.C.,Green, D.R.,York, J.D.,Carette, J.E.,Moldoveanu, T.
Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites.
Cell Chem Biol, 26:863-, 2019
Cited by
PubMed Abstract: Necroptosis is an inflammatory form of programmed cell death executed through plasma membrane rupture by the pseudokinase mixed lineage kinase domain-like (MLKL). We previously showed that MLKL activation requires metabolites of the inositol phosphate (IP) pathway. Here we reveal that I(1,3,4,6)P, I(1,3,4,5,6)P, and IP promote membrane permeabilization by MLKL through directly binding the N-terminal executioner domain (NED) and dissociating its auto-inhibitory region. We show that IP and inositol pentakisphosphate 2-kinase (IPPK) are required for necroptosis as IPPK deletion ablated IP production and inhibited necroptosis. The NED auto-inhibitory region is more extensive than originally described and single amino acid substitutions along this region induce spontaneous necroptosis by MLKL. Activating IPs bind three sites with affinity of 100-600 μM to destabilize contacts between the auto-inhibitory region and NED, thereby promoting MLKL activation. We therefore uncover MLKL's activating switch in NED triggered by a select repertoire of IP metabolites.
PubMed: 31031142
DOI: 10.1016/j.chembiol.2019.03.010
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon